comparemela.com

Latest Breaking News On - Biomedicine group - Page 5 : comparemela.com

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV

Home / Top News / ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities.

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders . Halper Sadeh LLPJanuary 16, 2021 GMT NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options.

MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm

SHAREHOLDER ALERT: WeissLaw LLP Reminds VSPR, CIT, ACAM, and CBMG Shareholders About Its Ongoing Investigations

Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) in connection with the company s proposed merger with privately-held The HydraFacial Company ( HydraFacial ).  Under the terms of the agreement, VSPR will acquire HydraFacial through a reverse merger that will result in HydraFacial becoming a publicly traded company.  If you own VSPR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/vspr/  

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.